MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Prevalence and influence of co-pathologies in patients with autopsy-confirmed Lewy body disorders: A systematic review

    D. Breen, E. Ravid, A. Lang, J. Miyasaki, R. Camicioli (Toronto, ON, Canada)

    Objective: To determine the prevalence of selected co-pathologies in patients with Lewy Body disorders, as well as their influence on disease expression. Background: The presence…
  • 2018 International Congress

    Clinical and genetic data of Huntington disease in Uzbekistan patient

    M. Rakhimova (Tashkent, Uzbekistan)

    Objective: Huntington's disease (HD) occurs worldwide with prevalence varying from 0.1 to 10/100,000 depending of the ethnic origin. Since no data is available in the…
  • 2018 International Congress

    Malignant gliomas in patients with Huntington’s disease

    S. Chandra, G. Suarez-Cedeno, E. Stimming (Houston, TX, USA)

    Objective: Discuss the presentation of glioblastoma multiforme in patients with Huntington’s disease Background: Huntington’s disease (HD) is an inherited neurodegenerative disorder caused by a trinucleotide…
  • 2018 International Congress

    REM sleep-related episodes in children with Narcolepsy type 1 after treatment with Sodium Oxybate

    E. Antelmi, F. Pizza, G. Plazzi (Bologna, Italy)

    Objective: We aimed to analyze the effect of Sodium Oxybate (SO) on motor events occurring during nighttime in children affected with Narcolepsy type 1 (NT1).…
  • 2018 International Congress

    The severity of motor symptoms and depression are the higher predictor for the decrease in daily living activities independence in people with Parkinson’s disease

    C. Dionizio Dias, E. Okamoto, C. Miranda, M. d'Alencar, M.E. Piemonte (São Paulo, Brazil)

    Objective: The purpose of this study was to identify among several motor, cognitive and mental measures which has higher power to predict the reduction in…
  • 2018 International Congress

    Surface Modified Solid Lipid Nanoparticles for the targeted delivery to brain: Management of HIV-1 Associated Dementia

    S. Bhargava, V. Bhargava (Kanpur, India)

    Objective: In this study, nifedipine loaded solid lipid nanoparticles (SLN) were developed for targeting drug into the central nervous system, the site of action of…
  • 2018 International Congress

    A53T mutant human α-synuclein BAC transgenic mice as a model for Parkinson’s disease

    T. Taguchi, I. Masashi, M. Uemura, Y. Hatanaka, N. Uemura, H. Yamakado, R. Takahashi (Kyoto, Japan)

    Objective: The aim of this study is to create mouse models reproducing the course of PD pathology and symptoms. Background: Parkinson's disease (PD) is a…
  • 2018 International Congress

    Evidence based management of Normal Pressure Hydrocephalus: Lessons and future directions

    A. Mahajan, M. Macki, M. Kaur, M. Novikova, R. Shatz, J. Schwalb (Detroit, MI, USA)

    Objective: To present the methodology and management tree of patients referred to the Henry Ford NPH conference for an evaluation from 2003 to 2017. Background:…
  • 2018 International Congress

    Cerebellar signs in progressive supranuclear palsy

    D. Crosiers, A. Sieben, J. Baets, J.J. Martin, P. Cras (Edegem, Belgium)

    Objective: To present a patient with cerebellar ataxia and a pathologically confirmed diagnosis of PSP. Background: Progressive supranuclear palsy (PSP) is an atypical form of…
  • 2018 International Congress

    MSA Preliminary Panamerican Report

    M. Cesarini, E. Gatto, J. Etcheverry, G. Da Prat, N. Gonzalez Rojas, H. Teive, M. Rodriguez, J. Ziliani, M. Miranda, P. Chana, F. Cardoso, A. Cardozo, C. Uribe Roca, I. Amorin, L. Abaroa, c. Cosentino, Y. Nuñez, A. Lescano, E. Dieguez, A. Alleva, I. Litvan, G. Wenning (La Plata, Argentina)

    Objective: To report the results of the PAN American MSA (PANMSA) database Background: Multiple system atrophy (MSA) is a rare neurodegenerative disease and coordinated efforts…
  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley